Ranbaxy CEO: Mulling Buying FDA-Approved Facilities

Ranbaxy Laboratories CEO Malvinder Mohan Singh said his firm was considering acquiring manufacturing facilities that already have approval from the U.S. Food and Drug Administration (FDA).
CNBC